| Trial ID: | L1195 |
| Source ID: | NCT03526536
|
| Associated Drug: |
Iv Novolin R Human Insulin
|
| Title: |
Pilot: Insulin Sensitivity/Management in Hyperglycemic Patients in Perioperative Period ESRD/Non-ESRD
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End-Stage Renal Disease|Diabetes Mellitus
|
| Interventions: |
DRUG: IV Novolin R human insulin
|
| Outcome Measures: |
Primary: Change in blood glucose level, Change in blood glucose level measures using a glucometer (Nova Biomedical, Waltham, MA. USA), one hour |
|
| Sponsor/Collaborators: |
Sponsor: State University of New York - Downstate Medical Center
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
40
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
|
| Start Date: |
2018-05-01
|
| Completion Date: |
2020-09-03
|
| Results First Posted: |
|
| Last Update Posted: |
2020-10-26
|
| Locations: |
SUNY Downstate Medical Center, Brooklyn, New York, 11203, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT03526536
|
